The new NICE guidance recommends that most people should now be offered metformin along with an SGLT-2 inhibitor from the start, while also advising that they get a slow-release formulation of ...

People diagnosed with type 2 diabetes before age 40 face a higher lifetime risk of heart and kidney problems, so may benefit from adding another type of medicine called a GLP-1 receptor agonist (such ...

Statistics indicate that type 2 diabetes (T2D) affects approximately 14% of the global population. This is significant because T2D is linked to various complications, including vision loss, kidney ...

The new type 2 diabetes treatment algorithm consensus statement from the American Association of Clinical Endocrinologists (AACE), running to 48 pages, has been published online and is available for ...

The usefulness and relevance of diabetes clinical guidelines are beyond doubt. Their use is widespread among internal medicine clinicians, though they have a weakness: “The most relevant information ...

.

A UC San Francisco analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new ...

The Food and Drug Administration recently approved Belgium-based Janssen Pharmaceuticals’ drug Invokamet XR for first-line use to improve glycemic control in diabetic adults when paired with diet and ...

Living with diabetes doesn’t have to mean accepting a lifetime of increasing medication doses and constant worry about blood sugar spikes. While traditional medical approaches focus heavily on ...

Yahoo College & High School Sports is powered by On3, delivering expert recruiting, NIL, and transfer portal news. Type 2 diabetes occurs when the body does not use insulin effectively or does not ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.